NCT05572099View on ClinicalTrials.gov

ExoDx Prostate Evaluation in Active Surveillance Patient Population

UnknownOBSERVATIONAL
Enrollment

750

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

ExoDx Prostate

Observational only.

Trial Locations (1)

21204

RECRUITING

Chesapeake Urology, Towson

Sponsors
All Listed Sponsors
lead

Exosome Diagnostics, Inc.

INDUSTRY